Schizophrenia News and Research

Latest Schizophrenia News and Research

Novel tool that can be used to visualize single neurons in living brain tissue

Carnegie Mellon University neuroscientist Alison Barth has developed the first tool to identify and study individual neurons activated in a living animal.

15 Jul 2004

Texas Medication Algorithm Project guidelines produce improvements in patients with major depressive disorder

Results from a multiyear study of severely depressed patients treated according to guidelines established by researchers at UT Southwestern Medical Center at Dallas showed a significant improvement in patients' symptoms and medical outcomes.

5 Jul 2004

British people should get out in the sun and not cover up for health reasons

British health is being put at risk by government policy that discourages sunbathing and promotes use of sunblock products. The cost of disease caused by insufficient exposure to sunlight and consequent deficiency of vitamin D is estimated to be billions of pounds per year in Britain.

5 Jul 2004

People who suffer from severe depression have more nerve cells in the part of the brain that controls emotion

Studies of postmortem brains of patients diagnosed with major depressive disorder (MDD) showed a 31 percent greater than average number of nerve cells in the portion of the thalamus involved with emotional regulation.

2 Jul 2004

Brain recordings may shed light on disorders of self-perception such as schizophrenia, stroke and phantom limb syndrome

Scientists have made the first recordings of the human brain’s awareness of its own body, using the illusion of a strategically-placed rubber hand to trick the brain.

2 Jul 2004

A Center for Human Genetics/Genomics has been established at the University of California

Established in UCSD Health Sciences, which includes the School of Medicine and School of Pharmacy and Pharmaceutical Sciences, the Center brings together UCSD faculty from multiple campus departments and schools including medicine, pharmacy, biology, biostatistics and mathematics.

30 Jun 2004

Nighttime surge of ghrelin may point to new targets for treating obesity

UCLA scientists have discovered that lean people experience a huge nighttime surge of ghrelin — the hormone that stimulates hunger — but obese people do not.

29 Jun 2004

Sex hormones alter the development of certain brain structures during puberty

The results, in press with NeuroImage, show that sex hormones alter the development of certain brain structures during puberty and that these effects persist into adulthood.

29 Jun 2004

Latest research into schizophrenia and links between prenatal vitamin D and growth

The latest research into schizophrenia and links between prenatal vitamin D and growth will be revealed at a public lecture at the Queensland Art Gallery, Australia next Friday (June 25).

17 Jun 2004

Marijuana/Cannabis causes transient schizophrenia-like symptoms

The principal active ingredient in marijuana causes transient schizophrenia-like symptoms ranging from suspiciousness and delusions to impairments in memory and attention, according to a Yale research study.

15 Jun 2004

Caring for schizophrenics, more action needed

About one per cent of Scots have a diagnosis of schizophrenia, and schizophrenia care accounts for about five per cent of total NHS costs.

15 Jun 2004

Drink that enhances the effectiveness of medication given to treat psychiatric illnesses

Scientists funded by the UK's largest biomedical research charity, The Wellcome Trust, have developed a drink that enhances the effectiveness of medication given to treat psychiatric illnesses such as mania and schizophrenia.

10 Jun 2004

Adrenaline packs a powerful punch in the use of antidepressants

Researchers from the University of Pennsylvania School of Medicine found that norepinephrine (adrenaline) plays an important role in animals in determining behavioral effects in some of the most commonly prescribed antidepressants, regardless of which biochemical pathway the drug uses to alleviate symptoms of depression.

3 Jun 2004

Antipsychotic compound bifeprunox worth USD 1 billion per year to Solvay and Wyeth

Solvay has re-evaluated the commercial potential of bifeprunox, a Solvay compound in clinical development for the treatment of schizophrenia . Bifeprunox additionally has the potential to be developed in other disorders, i.e. bipolar disorder.

3 Jun 2004

Compulsive hoarding study could improve diagnosis and treatment of psychiatric disorders

A PET imaging study conducted at the UCLA Neuropsychiatric Institute indicates the neurobiology of America's estimated 1 million compulsive hoarders differs significantly from people with other obsessive-compulsive disorder (OCD) symptoms. The findings indicate that different medications could improve treatment success.

2 Jun 2004

Schizophrenics who fail to take their medicines are over one-and-a-half times as likely to be rehospitalised

Patients with schizophrenia who fail to take their medicines as prescribed are over one-and-a-half times as likely to be rehospitalised and use in-patient services as patients who stick to their medication regimen. Non-adherence predicted an excess annual cost per patient of £5000 for total service use.

2 Jun 2004

Good evidence that genes play an important role in causing schizophrenia

There is good evidence that genes play an important role in causing schizophrenia. The disease prevalence is higher among blood relatives than non-related people and males are affected more frequently than females.

26 May 2004

Study helps to visualize how brain develops with age

The brain's center of reasoning and problem solving is among the last to mature, a new study graphically reveals. The decade-long magnetic resonance imaging (MRI) study of normal brain development, from ages 4 to 21, by researchers at NIH's National Institute of Mental Health (NIMH) and University of California Los Angeles (UCLA) shows that such "higher-order" brain centers, such as the prefrontal cortex, don't fully develop until young adulthood.

18 May 2004

Magnetic brain therapy may help spinal cord damage

A preliminary study has shown for the first time that it may be possible to help people who have suffered partial damage to their spinal cord by applying a magnetic therapy to their brain.

11 May 2004

Research will test the effectiveness of new drug treatments for the cognitive deficits of schizophrenia

The National Institute of Mental Health (NIMH), of the National Institutes of Health (NIH), has awarded a four-year, $9 million contract to the University of California, Los Angeles (UCLA) and five other academic medical centers to create a network of Treatment Units for Research on Neurocognition and Schizophrenia (TURNS).

8 May 2004

Schizophrenia News and Research

Latest Schizophrenia News and Research

Novel tool that can be used to visualize single neurons in living brain tissue

Texas Medication Algorithm Project guidelines produce improvements in patients with major depressive disorder

British people should get out in the sun and not cover up for health reasons

People who suffer from severe depression have more nerve cells in the part of the brain that controls emotion

Brain recordings may shed light on disorders of self-perception such as schizophrenia, stroke and phantom limb syndrome

A Center for Human Genetics/Genomics has been established at the University of California

Nighttime surge of ghrelin may point to new targets for treating obesity

Sex hormones alter the development of certain brain structures during puberty

Latest research into schizophrenia and links between prenatal vitamin D and growth

Marijuana/Cannabis causes transient schizophrenia-like symptoms

Caring for schizophrenics, more action needed

Drink that enhances the effectiveness of medication given to treat psychiatric illnesses

Adrenaline packs a powerful punch in the use of antidepressants

Antipsychotic compound bifeprunox worth USD 1 billion per year to Solvay and Wyeth

Compulsive hoarding study could improve diagnosis and treatment of psychiatric disorders

Schizophrenics who fail to take their medicines are over one-and-a-half times as likely to be rehospitalised

Good evidence that genes play an important role in causing schizophrenia

Study helps to visualize how brain develops with age

Magnetic brain therapy may help spinal cord damage

Research will test the effectiveness of new drug treatments for the cognitive deficits of schizophrenia

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Schizophrenia News and Research

Latest Schizophrenia News and Research

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Newsletters you may be interested in